A Clinical Trial of Infliximab for Uveitis
NCT00273390
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Uveitis
Interventions
DRUG:
Remicade (infliximab)
Sponsor
Oregon Health and Science University
Collaborators
[object Object]